Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Jalving

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2025
Heterogeneity of CD8 T-Cell Changes in Advanced Melanomas After Initiation of ImmunotherapyJahlisa S Hooiveld-Noeken, Laura Kist de Ruijter, Pim P van de Donk, et al.
The Lancet Regional Health. Europe|March 11, 2024
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access ProtocolKarlijn Verkerk, Birgit S Geurts, Laurien J Zeverijn, et al.
Nature Medicine|December 5, 2022
Whole-body CD8<sup>+</sup> T cell visualization before and during cancer immunotherapy: a phase 1/2 trialLaura Kist de Ruijter, Pim P van de Donk, Jahlisa S Hooiveld-Noeken, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2026
Translating ctDNA into cutaneous melanoma care: An international expert surveyGlenn Geidel, Nathan Fekade, Katharina Raabe, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2021
The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysisJudith M Versluis, Anne M Hendriks, Alison M Weppler, et al.
Gynecologic Oncology|May 25, 2024
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriersIris A S Stroot, Joost Bart, Harry Hollema, et al.
Cancers|June 10, 2023
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint InhibitorsOlivier J van Not, Thijs T Wind, Rawa K Ismail, et al.
Blood Advances|April 18, 2025
Atezolizumab Consolidation in Patients with High Risk Diffuse Large B-cell Lymphoma in Complete Remission after R-CHOPMarcel Nijland, Djamila E Issa, Johanna A A Bult, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2025
Heterogeneity of CD8 T-Cell Changes in Advanced Melanomas After Initiation of ImmunotherapyJahlisa S Hooiveld-Noeken, Laura Kist de Ruijter, Pim P van de Donk, et al.
The Lancet Regional Health. Europe|March 11, 2024
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access ProtocolKarlijn Verkerk, Birgit S Geurts, Laurien J Zeverijn, et al.
Nature Medicine|December 5, 2022
Whole-body CD8<sup>+</sup> T cell visualization before and during cancer immunotherapy: a phase 1/2 trialLaura Kist de Ruijter, Pim P van de Donk, Jahlisa S Hooiveld-Noeken, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2026
Translating ctDNA into cutaneous melanoma care: An international expert surveyGlenn Geidel, Nathan Fekade, Katharina Raabe, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2021
The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysisJudith M Versluis, Anne M Hendriks, Alison M Weppler, et al.
Gynecologic Oncology|May 25, 2024
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriersIris A S Stroot, Joost Bart, Harry Hollema, et al.
Cancers|June 10, 2023
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint InhibitorsOlivier J van Not, Thijs T Wind, Rawa K Ismail, et al.
Blood Advances|April 18, 2025
Atezolizumab Consolidation in Patients with High Risk Diffuse Large B-cell Lymphoma in Complete Remission after R-CHOPMarcel Nijland, Djamila E Issa, Johanna A A Bult, et al.
Pageof 8